Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
ViCentra Closes EUR 65M (USD 74M) Series C Funding to Expand Footprint of World’s Smallest Insulin Pump Across Europe
ViCentra, the company behind Kaleido, the world’s smallest and lightest wearable insulin pump (“patch pump”), announces […]
Antengene and XtalPi Announce AI-Driven R&D Collaboration
Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, […]
CELLINK and Nanoscribe Join Forces to Launch the Quantum X Bio, the World’s Most Accurate 3D Bioprinter
Today, BICO companies CELLINK and Nanoscribe announced the launch of the Quantum X bio, a revolutionary printing platform providing […]
Avacta Announces AffiDx SARS-CoV-2 Antigen Lateral Flow Test Detects the Omicron Variant
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful […]
BostonGene and NEC Announce Global Partnership
BostonGene Corporation and NEC Corporation (TSE: 6701) today announced a strategic global partnership agreement that will […]
Limbach Group Adopts QuantaMatrix dRASTTM in Routine Clinical Use
QuantaMatrix, an in vitro diagnostics company specializing in the discovery, development and commercialization of fully-integrated solutions within […]
Smart Fertility Test Gets Green Light for Home and Professional Use
Swiss medtech company Bloom Diagnostics today announced European approval for its Bloom Ovarian Reserve Test, […]
PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today […]
Sobi Continues the R&D Transformation - Anders Ullman Appointed New Head of R&D
Anders Ullman, M.D., Ph.D., currently a member of the Board of Directors of Sobi, will […]
NHS to Offer Booster Booking to Every Adult by End of December
The NHS vaccination programme will offer every adult the chance to book a covid-19 booster […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more